Efficacy and safety outcomes of real-world off label anifrolumab use in CLE with or without concomitant SLE: a systematic literature review (ACR Convergence 2026) - Sep 8, 2026 - Abstract #1175; Pres time: Nov 9, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Clinical • Real-world • Real-world evidence • Review • Inflammatory Arthritis
|
|
Ruth Ann Vleugels, MD,MPH,MBA
|